ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Balance Sheet
NASDAQ:ARQT - US03969K1088 - Common Stock
15.49 USD
-0.16 (-1.02%)
15.44 USD
-0.05 (-0.32%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 72.74M | 71.33M | 88.40M | 53.60M | 96.40M | |||
| Marketable Securities | 118.08M | 156.62M | 183.46M | 355.90M | 290.60M | |||
| Receivables | 106.69M | 73.07M | 25.81M | 8.50M | 400.00K | |||
| Inventories | 16.32M | 14.53M | 13.13M | 7.50M | N/A | |||
| Other Current Assets | 18.94M | 20.27M | 19.63M | 11.80M | 15.30M | |||
| Total Current Assets | 332.78M | 335.82M | 330.43M | 437.40M | 402.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.12M | 2.99M | 3.90M | 4.60M | 5.30M | |||
| Intangibles | 15.94M | 9.48M | 6.44M | 7.20M | N/A | |||
| Other Non-Current Assets | 596.00K | 596.00K | 596.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 19.66M | 13.07M | 10.93M | 11.90M | 5.40M | |||
| TOTAL ASSETS | 352.43M | 348.89M | 341.37M | 449.30M | 408.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.00M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 87.85M | 66.79M | 34.68M | 29.00M | 26.00M | |||
| Accounts Payable | 15.08M | 14.22M | 11.99M | 8.80M | 7.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 103.94M | 81.01M | 46.67M | 37.80M | 33.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 107.05M | 107.20M | 201.80M | 197.80M | 72.40M | |||
| Other Non-Current Liabilities | 2.47M | 3.13M | 4.23M | 4.10M | 4.80M | |||
| Total Non-Current Liabilities | 109.52M | 110.33M | 206.03M | 201.90M | 77.20M | |||
| TOTAL LIABILITIES | 213.46M | 191.35M | 252.70M | 239.70M | 110.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.16B | -1.12B | -981.90M | -719.80M | -408.30M | |||
| Additional Paid In Capital | 1.30B | 1.28B | 1.07B | 930.40M | 706.20M | |||
| Common Shares | 12.00K | 12.00K | 9.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -35.00K | -7.00K | 4.00K | -1.10M | -300.00K | |||
| Shares Outstanding | 119.80M | 117.85M | 96.79M | 61.00M | 50.30M | |||
| Tangible Book Value per Share | 1.03 | 1.26 | 0.85 | 3.32 | 5.92 | |||
| Total Shareholders' Equity | 138.97M | 157.54M | 88.67M | 209.60M | 297.70M | |||
| TOTAL LIABILITIES AND EQUITY | 352.43M | 348.89M | 341.37M | 449.30M | 408.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.77 | 0.68 | 2.28 | 0.94 | 0.24 | |||
| Current Ratio | 3.20 | 4.15 | 7.08 | 11.57 | 12.10 | |||
| Return On Assets (ROA) | -26.46% | -40.14% | -76.79% | -69.32% | -50.55% | |||
| Return On Equity (ROE) | -67.11% | -88.89% | -295.65% | -148.60% | -69.32% | |||
All data in USD , ROIC based on taxRate of 0.21